Literature DB >> 8491331

Preliminary report of unexpected local reactions to a progestogen-releasing contraceptive vaginal ring.

W Bounds1, A Szarewski, D Lowe, J Guillebaud.   

Abstract

This is the first report of vaginal erythematous areas associated with the use of a levonorgestrel-releasing contraceptive ring. Of 139 female subjects, 48 developed lesions of varying size and degrees of redness. Sixteen of these have undergone serial colposcopy and thirteen have also had biopsy examinations, which revealed acetowhite areas and, histologically, chronic inflammation with widely dilated vessels and frequently with thinning of the epithelium. The cause remains uncertain but hormonal, chemical and physical effects might all have a role.

Entities:  

Keywords:  Biology; Cervical Effects; Cervix; Clinical Research; Clinical Trials; Colposcopy; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Developed Countries; Diseases; Endoscopy; England; Europe; Examinations And Diagnoses; Family Planning; Genitalia; Genitalia, Female; Histology; Hpv; Levonorgestrel; Neoplasms; Northern Europe; Physical Examinations And Diagnoses; Physiology; Prospective Studies; Research Methodology; Research Report; Signs And Symptoms; Studies; United Kingdom; Urogenital System; Uterus; Vaginal Rings--side effects; Viral Diseases

Mesh:

Substances:

Year:  1993        PMID: 8491331     DOI: 10.1016/0028-2243(93)90252-8

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  7 in total

1.  Engineering a degradable polyurethane intravaginal ring for sustained delivery of dapivirine.

Authors:  Manpreet Kaur; Kavita M Gupta; Azadeh E Poursaid; Prasoona Karra; Alamelu Mahalingam; Hyder A Aliyar; Patrick F Kiser
Journal:  Drug Deliv Transl Res       Date:  2011-06       Impact factor: 4.617

2.  Monitoring vaginal epithelial thickness changes noninvasively in sheep using optical coherence tomography.

Authors:  Kathleen L Vincent; Gracie Vargas; Jingna Wei; Nigel Bourne; Massoud Motamedi
Journal:  Am J Obstet Gynecol       Date:  2013-01-17       Impact factor: 8.661

3.  A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.

Authors:  Todd J Johnson; Meredith R Clark; Theodore H Albright; Joel S Nebeker; Anthony L Tuitupou; Justin T Clark; Judit Fabian; R Tyler McCabe; Neelima Chandra; Gustavo F Doncel; David R Friend; Patrick F Kiser
Journal:  Antimicrob Agents Chemother       Date:  2012-09-24       Impact factor: 5.191

Review 4.  Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies.

Authors:  Andrea Ries Thurman; Meredith R Clark; Jennifer A Hurlburt; Gustavo F Doncel
Journal:  Int J Womens Health       Date:  2013-10-21

5.  Randomized, placebo controlled phase I trial of safety, pharmacokinetics, pharmacodynamics and acceptability of tenofovir and tenofovir plus levonorgestrel vaginal rings in women.

Authors:  Andrea Ries Thurman; Jill L Schwartz; Vivian Brache; Meredith R Clark; Timothy McCormick; Neelima Chandra; Mark A Marzinke; Frank Z Stanczyk; Charlene S Dezzutti; Sharon L Hillier; Betsy C Herold; Raina Fichorova; Susana N Asin; Christiane Rollenhagen; Debra Weiner; Patrick Kiser; Gustavo F Doncel
Journal:  PLoS One       Date:  2018-06-28       Impact factor: 3.240

6.  Development of Hormonal Intravaginal Rings: Technology and Challenges.

Authors:  Fojan Rafiei; Hadi Tabesh; Shayan Farzad; Farah Farzaneh; Maryam Rezaei; Fateme Hosseinzade; Khosrow Mottaghy
Journal:  Geburtshilfe Frauenheilkd       Date:  2021-07-13       Impact factor: 2.915

Review 7.  Sustained Release Drug Delivery Applications of Polyurethanes.

Authors:  Michael B Lowinger; Stephanie E Barrett; Feng Zhang; Robert O Williams
Journal:  Pharmaceutics       Date:  2018-05-09       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.